126 related articles for article (PubMed ID: 22582509)
21. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
Horacek JM; Pudil R; Tichy M; Jebavy L; Zak P; Slovacek L; Maly J
Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
[TBL] [Abstract][Full Text] [Related]
22. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
[TBL] [Abstract][Full Text] [Related]
23. Correlation between serum cardiac markers and myocardial infarct size quantified by myocardial perfusion imaging in patients with hypertrophic cardiomyopathy after alcohol septal ablation.
Hage FG; Aqel R; Aljaroudi W; Heo J; Pothineni K; Hansalia S; Lawson D; Dubovsky E; Iskandrian AE
Am J Cardiol; 2010 Jan; 105(2):261-6. PubMed ID: 20102929
[TBL] [Abstract][Full Text] [Related]
24. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of cardiac troponin I and other marker proteins in patients with chronic renal failure.
Nakai K; Nakai K; Nagane Y; Obara W; Sato M; Ohi K; Matsumoto N; Takanashi N; Itoh C
Clin Exp Nephrol; 2004 Mar; 8(1):43-7. PubMed ID: 15067515
[TBL] [Abstract][Full Text] [Related]
26. Elevated CK-MB mass and plasma brain-type natriuretic peptide concentrations following convulsive seizures in children and adolescents: possible evidence of subtle cardiac dysfunction.
Alehan F; Erol I; Cemil T; Bayraktar N; Ogüs E; Tokel K
Epilepsia; 2009 Apr; 50(4):755-60. PubMed ID: 19183225
[TBL] [Abstract][Full Text] [Related]
27. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.
Tsutamoto T; Kawahara C; Nishiyama K; Yamaji M; Fujii M; Yamamoto T; Horie M
Am Heart J; 2010 Jan; 159(1):63-7. PubMed ID: 20102868
[TBL] [Abstract][Full Text] [Related]
28. Cardiac troponin monitoring for detection of myocardial infarction: newer generation assays are here to stay.
Apple FS
Clin Chim Acta; 2007 May; 380(1-2):1-3; discussion 245-6. PubMed ID: 17306782
[No Abstract] [Full Text] [Related]
29. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
[TBL] [Abstract][Full Text] [Related]
30. Troponin T or troponin I or CK-MB (or none?).
Collinson PO
Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
[TBL] [Abstract][Full Text] [Related]
31. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction.
Kavsak PA; MacRae AR; Newman AM; Lustig V; Palomaki GE; Ko DT; Tu JV; Jaffe AS
Clin Chim Acta; 2007 May; 380(1-2):213-6. PubMed ID: 17306781
[TBL] [Abstract][Full Text] [Related]
32. The incremental benefit of a shortness-of-breath biomarker panel in emergency department patients with dyspnea.
Singer AJ; Thode HC; Green GB; Birkhahn R; Shapiro NI; Cairns C; Baumann BM; Aghababian R; Char D; Hollander JE
Acad Emerg Med; 2009 Jun; 16(6):488-94. PubMed ID: 19388909
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction.
Eggers KM; Oldgren J; Nordenskjöld A; Lindahl B
Am Heart J; 2004 Oct; 148(4):574-81. PubMed ID: 15459585
[TBL] [Abstract][Full Text] [Related]
34. A strategy for the use of cardiac injury markers (troponin I and T, creatine kinase-MB mass and isoforms, and myoglobin) in the diagnosis of acute myocardial infarction.
Kost GJ; Kirk JD; Omand K
Arch Pathol Lab Med; 1998 Mar; 122(3):245-51. PubMed ID: 9823862
[TBL] [Abstract][Full Text] [Related]
35. Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients.
Matsumura T; Saito T; Fujimura H; Shinno S
Brain Dev; 2007 Sep; 29(8):496-501. PubMed ID: 17376624
[TBL] [Abstract][Full Text] [Related]
36. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
[TBL] [Abstract][Full Text] [Related]
37. Authors' response to Apple editorial.
Kavsak PA; MacRae AR; Lustig V; Newman AM; Ko DT; Tu JV; Palomaki GE; Jaffe AS
Clin Chim Acta; 2007 May; 380(1-2):245-6. PubMed ID: 17328878
[No Abstract] [Full Text] [Related]
38. Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation.
Kozak KR; Hong TS; Sluss PM; Lewandrowski EL; Aleryani SL; Macdonald SM; Choi NC; Yock TI
Lung Cancer; 2008 Dec; 62(3):351-5. PubMed ID: 18462828
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
[TBL] [Abstract][Full Text] [Related]
40. Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction.
Fan J; Ma J; Xia N; Sun L; Li B; Liu H
Clin Lab; 2017 Mar; 63(3):427-433. PubMed ID: 28271683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
